Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins

Oncogene

Volumn 22, Issue 2, 2003, Pages 308-313

  Rushton, John J ^a   Davis, Lisa M ^a,c   Lei, Wanli ^a   Mo, Xianming ^d   Leutz, Achim ^d   Ness, Scott A ^a,b,e  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Exagen Diagnostics   (United States)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e NONE   (United States)

Author keywords

Breast cancer; Differentiation; Microarrays; Oncogenes; Transcription

Indexed keywords

DNA BINDING PROTEIN; PROTEIN; PROTEIN A MYB; PROTEIN B MYB; PROTEIN C MYB; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; DNA BINDING; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; MUTATION; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; UNINDEXED SEQUENCE; VIRUS RECOMBINANT;

ADENOVIRIDAE; BREAST; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TRANS-ACTIVATORS;

ADENOVIRIDAE; ANIMALIA;

EID: 0037448627     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206131     Document Type: Article

References (25)

1. Badiani P, Corbella P, Kioussis D, Marvel J and Weston K. (1994). Myb and NF-M: Genes Dev., 8, 770-782.
2. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B and Kinzler KW. (2001). Cancer Res., 61, 6996-7001.
3. Dash AB, Orrico FC and Ness SA. (1996). Genes Dev., 10, 1858-1869.
4. Foos G, Grimm S and Klempnauer K-H. (1994). Oncogene, 9, 2481-2488.
5. Foos G, Grimm S and Klempnauer K-H. (1992). EMBO J., 11, 4619-4629.
6. Gabrielli F, Donadel G, Bensi G, Heguy A and Melli M. (1995). Eur. J. Biochem., 232, 473-477.
7. Gerondakis S and Bishop JM. (1986). Mol. Cell Biol., 6, 3677-3684.
8. Guérin M, Sheng Z-M and Andrieu N. (1990). Oncogene, 5, 131-135.
9. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
10. Heinz S, Krause SW, Gabrielli F, Wagner HM, Andreesen R and Rehli M. (2002). Genomics, 79, 608-615.
11. Kamano H, Burk B, Noben-Trauth K and Klempnauer K-H. (1995). Oncogene, 11, 2575-2582.
12. Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J and Borg A. (2000). Cancer Res., 60, 5323-5328.
13. McClowry TL, Shors T and Brown DR. (2002). J. Med. Virol., 66, 96-101.
14. Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G and Ishii S. (1992). Oncogene, 7, 1233-1240.
15. Ness SA, (1996). BBA Rev. Cancer, 1288, F123-F139.
16. Ness SA. (1999). Oncogene, 18, 3039-3046.
17. Ness SA, Kowenz-Leutz E, Casini T, Graf T and Leutz A. (1993) Myb and NF-M:. Genes Dev., 7, 749-759.
18. Ness SA, Marknell Å and Graf T. (1989). Cell, 59, 1115-1125.
19. Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB and Jorcano JL. (1999). Mol. Cell Biol., 19, 3086-3094.
20. Rushton JJ and Ness SA. (2001). Blood Cells Mol. Dis., 27, 459-463.
21. Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K and Peschle C. (1997). Proc. Natl. Acad. of Sci. USA, 94, 532-536.
22. Stewart H, Black GC, Donnai D, Bonshek RE, McCarthy J, Morgan S, Dixon MJ and Ridgway AA. (1999). Ophthalmology, 106, 964-970.
23. Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J, Hatton KS and Reddy EP. (1997). Nature, 386, 713-717.
24. Trauth K, Mutschler B, Jenkins NA, Gilbert DJ, Copeland NG and Klempnauer K-H (1994). EMBO J., 13, 5994-6005.
25. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG and Court DL. (2000). Proc. Natl. Acad. Sci. USA, 97, 5978-5983.